Xortx calls special meeting of shareholders

Calgary, alberta, oct. 04, 2023 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that the company has called a special meeting of shareholders for 10:00 a.m. (calgary time) on october 25, 2023 (the “meeting”). materials for the meeting have been mailed to shareholders and are available on the company's sedar profile and the company's website.
XRTX Ratings Summary
XRTX Quant Ranking